PRN: Global Biosimilar Drugs Market - Forecast & Analysis to 2022 - In-depth Analysis at Regional & Country Level - Research and Markets

13/mar/2017 18:45:09 PR Newswire Turismo Contatta l'autore

Questo comunicato è stato pubblicato più di 1 anno fa. Le informazioni su questa pagina potrebbero non essere attendibili.

Global Biosimilar Drugs Market - Forecast & Analysis to 2022 - In-depth Analysis at Regional & Country Level - Research and Markets

 
[13-March-2017]
 

DUBLIN, Mar. 13, 2017 /PRNewswire/ --

Research and Markets has announced the addition of the "Global Biosimilar Drugs Market Analysis 2016 - Forecast to 2022" report to their offering.

Logo

The report contains up to date financial data derived from varied research sources to present unique and reliable analysis. Assessment of major trends with potential impact on the market during the next five years, including a deep dive analysis of market segmentation which comprises of sub markets, regional and country level analysis. The report provides a comprehensive outlook about the market share along with strategic recommendations based on the emerging segments.

This report analyzes the global markets for "Biosimilar Drugs". The market assessment is performed through standard and the tailored research methodology approach. The market overview offers in depth analysis at the regional and country level, for instance North America (U.S., Canada and Mexico), Europe (Germany, France, Italy, U.K. and Spain), Asia-Pacific (China, Japan, India, Australia, South Korea and Rest of APAC) and Rest of the World (Middle East, Africa! and Latin America).

Annual estimations and forecasts are provided from the year 2013 to 2022 for each given segment and sub segments. Market data derived from the authenticated and reliable sources is subjected to validation from the industry experts. The report also analyzes the market by discussing market dynamics such as drivers, constraints, opportunities, threats, challenges and other market trends.

Companies Mentioned

  • Abbott Laboratories
  • AET BioTech
  • Baxter International
  • Bayer
  • Becton, Dickinson and Company
  • Boehringer Ingelheim
  • Celgene Corporation
  • Cipla
  • Covidien
  • Dr. Reddy's Laboratories
  • Fujifilm Corporation
  • Johnson & Johnson
  • Kowa Company
  • LG Life Sciences
  • Merck and Co.
  • Pfizer Inc.
  • Mylan Inc.
  • F. Hoffmann-La Roche Ltd.
  • Novartis
  • Samsung Bioepis
  • Teva Pharmaceutical Industries Ltd.

Key Topics Covered:

1 Introduction

2 Executive Summary

3 Market Analysis

4 Porters Five Force Analysis

5 Biosimilar drugs Market by Drug Class

6 Biosimilar drugs Market by Manufacturing Type

7 Biosimilar drugs Market by Application

8 Geographical Segmentation

9 Vendor Landscaping

10 Company Profiles

For more information about this report visit http://www.researchandmarkets.com/research/rkhm47/global_biosimilar

Media Contact:

Laura Wood, Senior Manager
press@researchandmarkets.com  

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

 

blog comments powered by Disqus
Comunicati.net è un servizio offerto da Factotum Srl